Publication:

Impact of false-positive newborn metabolic screening results on early health care utilization

Loading...
Thumbnail Image

Date

2009

Journal Title

Journal ISSN

Volume Title

Publisher

Springer Nature
The Harvard community has made this article openly available. Please share how this access benefits you.

Research Projects

Organizational Units

Journal Issue

Citation

Lipstein, Ellen A, James M Perrin, Susan E Waisbren, and Lisa A Prosser. 2009. “Impact of False-Positive Newborn Metabolic Screening Results on Early Health Care Utilization.” Genetics in Medicine 11 (10) (August 5): 716–721. doi:10.1097/gim.0b013e3181b3a61e.

Abstract

Purpose: To analyze the association between false-positive newborn screening results and health care utilization. Methods: We surveyed parents regarding their children's health care utilization. Parents of children who received false-positive newborn screening results were primarily enrolled by a screening laboratory in Pennsylvania. Parents of children with normal results were recruited through the Massachusetts birth registry. We used bivariate tests and multivariate regression to assess the association between newborn screening results and primary care utilization, emergency room use, and hospitalization by age six months. Results: Our sample included 200 children with false-positive results and 137 with normal results. Variation in recruitment strategies led to sample children with false-positive results being more likely to be non-white, have unmarried parents and be of lower socioeconomic status. After adjusting for significant covariates, such as age, race and socioeconomic status, there were no significant associations between newborn screening results and child health care utilization. Conclusions: Despite the reported negative psychosocial effects of false-positive results, our study found no impact on early health care utilization. These results may assist in economic analyses of newborn screening as they suggest that medical costs associated with false-positive results are limited to the cost of diagnostic testing and follow-up.

Description

Research Data

Keywords

health services utilization, neonatal screening, false positive results, metabolic diseases, genetic diseases

Terms of Use

This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service

Endorsement

Review

Supplemented By

Related Stories